Samsung is testing Galaxy Watch 8 to prevent muscle loss on GLP-1s like Ozempic
Samsung is collaborating with Massachusetts General Hospital to investigate how the Galaxy Watch 8 can assist patients using GLP-1 medications like Ozempic in preventing muscle loss. The research aims to leverage wearable technology for health management in this patient group.
- Entities
- Topic: Health Monitoring
- Company: Massachusetts General Hospital
- Platform: Galaxy Watch 8
- Topic: Medical Research
- Company: Samsung
This article was reported and published by engadget.com. feed.gg links to it as part of a story cluster — full text, images and rights remain with the publisher.